Cargando…

Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment

BACKGROUND: Hyaluronic acid (HA) fillers are popular for the treatment of signs of facial skin aging. OBJECTIVE: The objective of this study was to confirm the performance and safety of a new cohesive polydensified matrix HA filler ([CPM(®)-HA20G, Belotero Revive(®), lidocaine-free], Merz Pharmaceut...

Descripción completa

Detalles Bibliográficos
Autores principales: Hertz-Kleptow, Dominique, Hanschmann, Angelika, Hofmann, Matthias, Reuther, Tilmann, Kerscher, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698156/
https://www.ncbi.nlm.nih.gov/pubmed/31496779
http://dx.doi.org/10.2147/CCID.S209256
_version_ 1783444505040519168
author Hertz-Kleptow, Dominique
Hanschmann, Angelika
Hofmann, Matthias
Reuther, Tilmann
Kerscher, Martina
author_facet Hertz-Kleptow, Dominique
Hanschmann, Angelika
Hofmann, Matthias
Reuther, Tilmann
Kerscher, Martina
author_sort Hertz-Kleptow, Dominique
collection PubMed
description BACKGROUND: Hyaluronic acid (HA) fillers are popular for the treatment of signs of facial skin aging. OBJECTIVE: The objective of this study was to confirm the performance and safety of a new cohesive polydensified matrix HA filler ([CPM(®)-HA20G, Belotero Revive(®), lidocaine-free], Merz Pharmaceuticals GmbH, Frankfurt, Germany) for the treatment of early signs of facial skin aging by use of biophysical measurements as well as subject and investigator satisfaction. METHODS: Twenty-five healthy female subjects with signs of facial skin aging were enrolled in this open-label, rater-blinded, observational post-market clinical follow-up study, and received 20 micropuncture treatments of 50 µL CPM(®)-HA20G each into the lower cheek area at three injection visits 4 weeks apart. Objective biophysical assessments were conducted to demonstrate effects on viscoelastic properties of the skin, surface roughness, tone and radiance, and hydration, at baseline and at all follow-up visits up to 36 weeks. RESULTS: CPM(®)-HA20G significantly increased gross elasticity of the skin (at weeks 9 and 12), skin firmness (up to week 24), skin tone and radiance and skin hydration (all up to 36 weeks). Significant reduction of skin fatigue (up to 9 weeks), skin roughness (up to 28 weeks), and redness (up to 36 weeks) was also observed. Subjects and blinded investigator were highly satisfied with the treatment outcomes. The treating investigator reported a high level of satisfaction with the ease of injection and the clinical performance of the device. Moreover, data demonstrated a good safety profile of the device. CONCLUSION: CPM(®)-HA20G is considered to be an effective and safe HA injectable for skin revitalization in patients suffering from signs of skin aging and loss of skin elasticity. It seems to be a perfect early intervention approach in patients that do not need volumizing treatment and a combination approach in older patients with more pronounced aging.
format Online
Article
Text
id pubmed-6698156
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66981562019-09-06 Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment Hertz-Kleptow, Dominique Hanschmann, Angelika Hofmann, Matthias Reuther, Tilmann Kerscher, Martina Clin Cosmet Investig Dermatol Original Research BACKGROUND: Hyaluronic acid (HA) fillers are popular for the treatment of signs of facial skin aging. OBJECTIVE: The objective of this study was to confirm the performance and safety of a new cohesive polydensified matrix HA filler ([CPM(®)-HA20G, Belotero Revive(®), lidocaine-free], Merz Pharmaceuticals GmbH, Frankfurt, Germany) for the treatment of early signs of facial skin aging by use of biophysical measurements as well as subject and investigator satisfaction. METHODS: Twenty-five healthy female subjects with signs of facial skin aging were enrolled in this open-label, rater-blinded, observational post-market clinical follow-up study, and received 20 micropuncture treatments of 50 µL CPM(®)-HA20G each into the lower cheek area at three injection visits 4 weeks apart. Objective biophysical assessments were conducted to demonstrate effects on viscoelastic properties of the skin, surface roughness, tone and radiance, and hydration, at baseline and at all follow-up visits up to 36 weeks. RESULTS: CPM(®)-HA20G significantly increased gross elasticity of the skin (at weeks 9 and 12), skin firmness (up to week 24), skin tone and radiance and skin hydration (all up to 36 weeks). Significant reduction of skin fatigue (up to 9 weeks), skin roughness (up to 28 weeks), and redness (up to 36 weeks) was also observed. Subjects and blinded investigator were highly satisfied with the treatment outcomes. The treating investigator reported a high level of satisfaction with the ease of injection and the clinical performance of the device. Moreover, data demonstrated a good safety profile of the device. CONCLUSION: CPM(®)-HA20G is considered to be an effective and safe HA injectable for skin revitalization in patients suffering from signs of skin aging and loss of skin elasticity. It seems to be a perfect early intervention approach in patients that do not need volumizing treatment and a combination approach in older patients with more pronounced aging. Dove 2019-08-13 /pmc/articles/PMC6698156/ /pubmed/31496779 http://dx.doi.org/10.2147/CCID.S209256 Text en © 2019 Hertz-Kleptow et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hertz-Kleptow, Dominique
Hanschmann, Angelika
Hofmann, Matthias
Reuther, Tilmann
Kerscher, Martina
Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment
title Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment
title_full Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment
title_fullStr Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment
title_full_unstemmed Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment
title_short Facial skin revitalization with CPM(®)-HA20G: an effective and safe early intervention treatment
title_sort facial skin revitalization with cpm(®)-ha20g: an effective and safe early intervention treatment
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698156/
https://www.ncbi.nlm.nih.gov/pubmed/31496779
http://dx.doi.org/10.2147/CCID.S209256
work_keys_str_mv AT hertzkleptowdominique facialskinrevitalizationwithcpmha20ganeffectiveandsafeearlyinterventiontreatment
AT hanschmannangelika facialskinrevitalizationwithcpmha20ganeffectiveandsafeearlyinterventiontreatment
AT hofmannmatthias facialskinrevitalizationwithcpmha20ganeffectiveandsafeearlyinterventiontreatment
AT reuthertilmann facialskinrevitalizationwithcpmha20ganeffectiveandsafeearlyinterventiontreatment
AT kerschermartina facialskinrevitalizationwithcpmha20ganeffectiveandsafeearlyinterventiontreatment